Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Celgene Corp (NASDAQ:CELG)

137.75
Delayed Data
As of Jul 26
 +1.31 / +0.96%
Today’s Change
96.93
Today|||52-Week Range
138.93
+19.01%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Operating ActivitiesNet Income / Starting Line598.2M171.4M428.9M941.0M
 
 
 
 
 
Depreciation125.3M115.9M138.2M121.0M
 
 
 
 
 
Total Other Cash Flow200.8M430.7M452.0M195.0M
 
 
 
 
 
Funds From Operations801.0M627.9M931.9M1.2B
 
 
 
 
 
Funds From/For Other Operating Expenses-135.0M-94.6M-411.0M324.0M
 
 
 
 
 
Net Cash Flow - Operating Activities936.0M722.5M1.3B853.0M
 
 
 
 
 
 
InvestingIncrease In Investments-156.8M-160.8M-730.4M-1.9B
 
 
 
 
 
Decrease In Investments125.1M115.5M92.6M266.0M
 
 
 
 
 
Capital Expenditures-43.7M-66.5M-66.4M-62.0M
 
 
 
 
 
Other Investing - Uses0.00-600.0K0.00--
 
 
Other Investing - Sources0.000.00--4.0M
 
 
Net Cash Flow Investing-75.4M-112.4M-704.2M-1.7B
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.00----
Long Term Borrowings----0.00----
Long Term Debt Reduction----0.00----
Net Proceeds Stock Sale16.5M116.7M168.3M184.0M
 
 
 
 
 
Common Preferred Redeemed-296.3M-320.1M-133.6M-293.0M
 
 
 
 
 
Common Dividends----------
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing57.0M47.7M59.0M0.00
 
 
 
 
Other Uses - Financing0.000.0041.1M0.00
 
 
Net Cash Flow - Financing-222.8M-155.7M52.6M-109.0M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-19.6M4.5M-44.0M19.0M
 
 
 
 
 
 
Net Change In Cash637.8M454.4M691.3M-916.0M